Oligonucleotide Synthesis. The oligonucleotides used in this study (Table S1) were synthesized using automated solid-support phosphoramidite synthesis on an Expedite 8909 Nucleotide Synthesis System (MM48 Synthesizer, Bioautomation, Plano, TX, USA) with DCI as an activator. The tocopherol phosphoramidite was coupled to the nucleic acid using the standard automated protocol with an extended coupling time of 15 minutes. After the completion of solid phase synthesis, the oligonucleotide strands were cleaved from the solid support by overnight treatment with aqueous ammonium hydroxide (28-30 wt% aqueous solution, Aldrich Chemicals, Milwaukee, WI, USA), after which the excess ammonia was removed using a gentle flow of nitrogen gas (house nitrogen was used). The oligonucleotides were purified using a Microsorb C18 column on a reverse-phase high pressure liquid chromatography system (Varian ProStar Model No. 210, Varian, Inc., Palo Alto, CA, USA) using a gradient of TEAA (triethylammonium acetate) buffer and acetonitrile (10% v/v to pure acetonitrile over 30 min).
The product-containing fractions were collected and concentrated on a lyophilizer. The oligonucleotides were re-suspended in ultrapure deionized water, and purity was analyzed using MALDI-TOF and denaturing acrylamide gel electrophoresis techniques. Table S1 . The oligonucleotides and oligonucleotide-modified materials used in this study.
Name of the strand

Application Sequence
Cy5-T 25 strand Size analysis, DNA density determination, and stability studies Synthesis of small unilamellar vesicles (SUVs). SUVs were synthesized using a modification of a published protocol. 1 An aliquot from the lipid monomer stock solution (1-2 mL, 25 mg/mL concentration) was added into a 25 mL glass vial, and the solvent was carefully evaporated using a stream of nitrogen. The obtained lipid monomer was further dried overnight under vacuum to remove the residual chloroform. The resulting lipid film was then hydrated with 20 mM HEPES-bufferred saline (HBS, 5.0 mL) followed by vortexing to form a liposomal suspension.
This suspension was further probe-sonicated for 30 min keeping the temperature of the lipid mixture below 10 °C with an ice-water bath. After sonication, the suspension was subjected to ultracentrifugation at 100,000 g for 90 min at 12 ºC. After centrifugation, the clear supernatant containing the desired small unilamellar vesicles (SUVs) was collected, and the pellet was discarded.
To obtain particles with a narrower size distribution, the obtained SUVs were further extruded Figure S1 ). The final phospholipid concentration in a given sample was determined by analyzing its phosphorus content by inductively coupled plasma mass spectrometry (ICP-MS).
Scheme S1. A schematic representation of the synthesis of small unilamellar vesicles. The larger size liposomes are sonicated into SUVs using a probe sonicator, separated from heavy impurities by ultracentrifugation. 1 . Figure S1 . TEM image of SUVs after isolation and purification.
Preparation of DNA-functionalized liposomal SNAs. To prepare liposomal SNAs, the desired 3'-tocopherol modified oligonucleotide (8 nmol) was added to an aliquot of the SUV solution (500 µL of a solution containing 1.3 mM phospholipid) and allowed to shake overnight. The solution was then purified by size-exclusion chromatography on a cross-linked sepharose column (Sepharose CL 4B, Aldrich Chemicals, Milwaukee, WI, USA); and the particle size distribution was analyzed using DLS. To observe the liposomal SNAs using TEM, the samples were placed onto plasma-cleaned carbon TEM grids and further stained with an aqueous solution of uranyl acetate (2 wt%) for 2 min, washed with water, and allowed to dry. The dried grid was imaged using a Hitachi-2300 STEM electron microscope ( Figure S2 ). The TEM-determined average particle diameter (25 ± 7 nm) is slightly smaller than that determined by DLS due to drying effects. Chemicals, Milwaukee, WI, USA) as described above; and then analyzed using gel electrophoresis. To quantitatively determine the average number of nucleic strands loaded onto the surface of a liposome, the liposomal SNAs solution (2.5 µL) was mixed with Triton X-100
(10 µL of a 5 wt% aqueous solution) and an aliquot of HBS buffer (100 µL). After vortexing the mixture for 1 min, the final nucleic acid concentration was determined by measuring the extinction at 260 nm relative to a calibrated oligonucleotide standard. The number of liposomes in the corresponding solution was calculated using the third equation shown in Scheme S2, with the assumption that the phospholipid concentration of the liposomes remains constant after functionalization and purification. From this number and the nucleic acid concentrations, the S6 average number of DNA per particle can be estimated to be ~70. We note that this surface coverage is lower than that in a typical gold-based SNA structure (a surface of 30 nm Au nanoparticle can be functionalized with up to 600 DNA strands).
2
Scheme S2. The calculation of the total number of liposomes in a given solution. Concentration of the lipid can be determined using ICP-MS. For most of the studies performed in this manuscript, the working lipid concentration 1.3 mM gives 1.361 × 10 17 liposomes/L.
Melting assays.
A two-nanoparticle system was formed using liposomal SNAs that were functionalized with strands complementary to the linker strand as described in Table S1 . The aggregates were formed by hybridizing two DNA-functionalized liposomal SNAs to a linker strand in a 1:1:1 ratio (total DNA concentration = 1.5 µM, total volume = 1 mL). The extinction spectra for the liposomal SNAs with the linker was collected using a Cary 5000 UV-Vis spectrometer and compared to the extinction spectra of liposomal SNAs without the linker (see Figure   S3 .
Figure S4.
The degradation of sulforhodamine-encapsulated SUVs (red traces) and liposomal SNAs (blue traces) in the presence of 10 vol% fetal bovine serum at 37 °C, as measured by increases in the fluorescence intensity of released sulforhodamine. The fluorescent profile of sulforhodamine-encapsulated SUVs in phosphatebuffered saline (PBS) at 37 °C (green traces) was also included as a control.
Cell culture studies. SKOV-3 cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) and grown in McCoy's 5A medium supplemented with fetal bovine serum (10 vol%), penicillin (0.2 units/mL), and streptomycin (0.1 µg/mL). Cells were maintained at standard cell culture conditions (at 37 °C in a humidified atmosphere with 5 % CO 2 ). For cellular studies, the cells were plated 24 hours prior to the treatment at 50%
confluency.
Confocal microscopy. 
